Exenatide (Byetta) was approved in 2005 and is administered as a subcutaneous injection twice daily, taken within 60 minutes before morning and evening meals
Studies have shown that allulose is well tolerated in children at doses of 2.5 to 4.3 grams per 120 ml, making it a good candidate for replacing added sugars in commercially produced goods for children
Rarely, some individuals may experience mild redness or itching, usually due to other ingredients in the formula rather than the peptide itself
Contact us to make an appointment for your initial evaluation
Whether GLP-1s are covered by insurance comes down almost entirely to the type of plan you have
Since GLP-1 patches arent FDA approved, theres no guarantee of quality or consistency, and they havent been tested in clinical trials, so theres no long-term safety data